Paper40248014
Association between peripheral blood serum phenylalanine to tyrosine ratio and the risk of moyamoya disease: a case-control study.
Lei S and 5 others. Front Neurol, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Association between peripheral blood serum phenylalanine to tyrosine ratio and the risk of moyamoya disease: a case-control study. Papers, record 40248014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40248014
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Association between peripheral blood serum phenylalanine to tyrosine ratio and the risk of moyamoya disease: a case-control study.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32618142 | Elevated plasma phenylalanine predicts mortality in critical patients with heart failure. | ESC Heart Fail | 2020 | https://conductscience.org/library/papers/32618142 | PubMed |
| 2 | 23990339 | Inflammation-induced catabolism of tryptophan and tyrosine in acute ischemic stroke. | J Mol Neurosci | 2013 | https://conductscience.org/library/papers/23990339 | PubMed |
| 3 | 23457044 | Phenylalanine hydroxylase: function, structure, and regulation. | IUBMB Life | 2013 | https://conductscience.org/library/papers/23457044 | PubMed |
| 4 | 11286377 | Phenylketonuria: tyrosine beyond the phenylalanine-restricted diet. | J Inherit Metab Dis | 2001 | https://conductscience.org/library/papers/11286377 | PubMed |
| 5 | 24660059 | Immune activation and inflammation in patients with cardiovascular disease are associated with higher phenylalanine to tyrosine ratios: the ludwigshafen risk and cardiovascular health study. | J Amino Acids | 2014 | https://conductscience.org/library/papers/24660059 | PubMed |
| 6 | 28381201 | Etiology and pathogenesis of Moyamoya Disease: An update on disease prevalence. | Int J Stroke | 2017 | https://conductscience.org/library/papers/28381201 | PubMed |
| 7 | 32640948 | Modifiable Risk Factors Associated With Moyamoya Disease: A Case-Control Study. | Stroke | 2020 | https://conductscience.org/library/papers/32640948 | PubMed |
| 8 | 33915296 | Medioresinol as a novel PGC-1α activator prevents pyroptosis of endothelial cells in ischemic stroke through PPARα-GOT1 axis. | Pharmacol Res | 2021 | https://conductscience.org/library/papers/33915296 | PubMed |
| 9 | 21799892 | Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. | PLoS One | 2011 | https://conductscience.org/library/papers/21799892 | PubMed |
| 10 | 31281171 | Influence of Inflammatory Disease on the Pathophysiology of Moyamoya Disease and Quasi-moyamoya Disease. | Neurol Med Chir (Tokyo) | 2019 | https://conductscience.org/library/papers/31281171 | PubMed |
| 11 | 17038954 | Caspase-3-dependent apoptosis in middle cerebral arteries in patients with moyamoya disease. | Neurosurgery | 2006 | https://conductscience.org/library/papers/17038954 | PubMed |
| 12 | 34756930 | Catecholamine-induced cardiotoxicity: A critical element in the pathophysiology of stroke-induced heart injury. | Life Sci | 2021 | https://conductscience.org/library/papers/34756930 | PubMed |
| 13 | 31488882 | Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression. | Cell Res | 2019 | https://conductscience.org/library/papers/31488882 | PubMed |
| 14 | 18701209 | Serum phenylalanine concentrations in patients with ovarian carcinoma correlate with concentrations of immune activation markers and of isoprostane-8. | Cancer Lett | 2008 | https://conductscience.org/library/papers/18701209 | PubMed |
| 15 | 18940695 | Moyamoya disease: current concepts and future perspectives. | Lancet Neurol | 2008 | https://conductscience.org/library/papers/18940695 | PubMed |
| 16 | 37962021 | Proteomic and metabolomic characterizations of moyamoya disease patient sera. | Brain Behav | 2023 | https://conductscience.org/library/papers/37962021 | PubMed |
| 17 | 32348841 | Tetrahydrobiopterin in energy metabolism and metabolic diseases. | Pharmacol Res | 2020 | https://conductscience.org/library/papers/32348841 | PubMed |
| 18 | 34529262 | The Genetic Basis of Moyamoya Disease. | Transl Stroke Res | 2022 | https://conductscience.org/library/papers/34529262 | PubMed |
| 19 | 27061063 | Serum Tyrosine-to-Phenylalanine Ratio is Low in Parkinson's Disease. | J Parkinsons Dis | 2016 | https://conductscience.org/library/papers/27061063 | PubMed |
| 20 | 32811391 | Familial Risk for Moyamoya Disease Among First-Degree Relatives, Based on a Population-Based Aggregation Study in Korea. | Stroke | 2020 | https://conductscience.org/library/papers/32811391 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42970223 | Proteomic and Metabolomic Profiling in Moyamoya Disease: A Systematic Review. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42970223 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40248014
GET https://conductscience.org/api/papers/v1/40248014/references?page=2